The XLH Network needs your support to continue to achieve our goal to discover better treatment and ultimately a cure for this rare and neglected heritable bone disease affecting 1 in 20,000 babies and adults worldwide. To date there is no cure for XLH and the current treatment is not always successful, and if not carefully monitored it can be damaging to organs. Your contribution helps our organization continue the support and fund ongoing research and bring awareness to pediatricians so our babies can be diagnosed at an early stage improving the future for every child and adult affected with XLH. We cannot exist without your donations every donation regardless of the amount can make the difference in achieving our Mission. It is the spirit of giving that really counts. The XLH Network is currently funded entirely by donations from those people whose hearts we've touched, and we are very grateful to those individuals.
There are many ways to help us:
You can contribute worldwide via PayPal or Credit Card:
~ OR ~
Checks (USA banks only) may be mailed to:
The XLH Network, Inc.
911 Central Ave., #161
Albany, NY 12206
?Other ways to help:
- Employer Matching Gift
Many employers have programs to match donations made by their employees. Check with your employer to see how to add The XLH Network, Inc. to their employer matching gift program.
- Planned Giving
Ask your financial and legal advisors about including The XLH Network, Inc. as a beneficiary in your will or whether there may be ways to help us that would also benefit you financially while you're still alive.
- Shop and search online to support The XLH Network, Inc. at:
Donate a vehicle to support The XLH Network, Inc. at:
- Fundraising Ideas
The XLH Network, Inc. is a not-for-profit corporation and is recognized in the USA as a tax-exempt 501(c)(3) publicly supported charitable organization.
© 2011, The XLH Network Inc.
The authors of this web site are not medical professionals, and this information does not substitute for medical care. Information on these pages is based on biomedical research, published in peer-reviewed journals, and international research conferences. Additionally, in some cases anecdotal information is provided by subscribers of the F-HYPDRR group, a mailing list for The XLH Network Inc. A listing of XLH research is available. Please read our full disclaimer.
- Advocacy with ASBMR
- It's easy to think of politicians as ignorant or foolish or self-aggrandizing, and I'm about as cynical as anyone, so I was pleasantly surprised by the experience of visiting Capitol Hill to advocate for sustained funding for basic science research at Nat…
- New NIH Research Study
- NIH Research Study: Open-label Dose-titration Study of the Tolerability and Efficacy of Cinacalcet to Treat Fibroblast Growth Factor 23 (FGF23)-mediated HypophosphatemiaPrincipal Investigator: Dr. Rachel Gafni, MDSponsoring Institute: Craniofaci…
- Rare Disease Week
- The last day of February each year is World Rare Disease Day. This year, it falls on February 28th.Here in the U.S., several medical-professional and patient-support groups have gotten together to make the entire week into a time of awareness and advocacy…
- The Social Media Flashlight: How Facebook Demystified XLH
- We have another guest post today, this time from Jennifer West. She's the mother of an XLHer, who lives and works in the Wisconsin Northwoods. She's also an antique-collector and nature-lover. 2009 was one crazy year. Our youngest child was born, and…